Why Is Allurion (ALUR) Stock Up 65% Today?

Little-known medical device firm Allurion (NYSE:ALUR) — which is focused on ending obesity via its swallowable and “procedure-less” intragastric balloon — saw its shares skyrocket on Thursday. Earlier this morning, management announced the commercial availability of its comprehensive Virtual Care Suite (VCS) in the U.S. ALUR stock likely benefited from rising interest in anti-obesity treatments.According to the company’s press release, the VCS is a dynamic weight-loss management suite powered by artificial ...